Collette, J., Bruyère, O., Vanoverberghe, M., & Reginster, J.-Y. (June 2010). Effect of strontium ranelate on serum osteoprotegerin in women with postmenopausal osteoporosis treated over three years. Annals of the Rheumatic Diseases, 69 (Suppl.3), 602. Peer Reviewed verified by ORBi |
Bruyère, O., Vanoverberghe, M., Neuprez, A., Ethgen, O., Zegels, B., Gillet, P., Huskin, J.-P., & Reginster, J.-Y. (June 2010). Health-related quality of life after total knee or hip replacement: a 7-year prospective study. Annals of the Rheumatic Diseases, 69 (Suppl.3), 469. Peer Reviewed verified by ORBi |
Bruyère, O., Vanoverberghe, M., Neuprez, A., Ethgen, O., Zegels, B., Gillet, P., Huskin, J.-P., & Reginster, J.-Y. (May 2010). Health-related quality of life after total knee or hip replacement : a 7-year prospective study. Osteoporosis International, 21 (Suppl.1), 26. Peer Reviewed verified by ORBi |
Collette, J., Bruyère, O., Vanoverberghe, M., & Reginster, J.-Y. (2010). Effect of strontium ranelate on serum osteoprotegerin in women with postmenopausal osteoporosis treated over three years. Osteoporosis International, 21 (Suppl.1), 311-312. Peer Reviewed verified by ORBi |
Hiligsmann, M., Vanoverberghe, M., Neuprez, A., Bruyère, O., & Reginster, J.-Y. (2010). Cost-effectiveness of strontium ranelate for the prevention and treatment of osteoporosis. Expert Review of Pharmacoeconomics and Outcomes Research, 10 (4), 359-366. doi:10.1586/erp.10.53 Peer Reviewed verified by ORBi |